| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
HAMBURG, Germany & TOKYO—In mid-march, Eppendorf AG and Koki Holdings Co. Ltd. reached an agreement that Eppendorf will acquire Koki’s centrifuge business, including the premium himac brand. The acquisition marks a targeted step by German company Eppendorf AG to expand its centrifuge business, and it says that the deal “solidifies its strong market position as one of the world’s leading makers of high-end centrifuges for the pharma and life-science industries, as well as academic and commercial research.”
 
“We are excited to acquire Koki’s centrifuge business and its premium himac brand. These high-performance products are an ideal fit for Eppendorf’s centrifuges business and high-quality standards,” stated Dr. Peter Fruhstorfer, co-CEO of Eppendorf AG. “With this acquisition, Eppendorf will become a full-line provider of high-performance premium centrifuges on a global level. This gives us access to new customer groups and offers opportunities for further growth.”
 
The centrifuge business is one of Eppendorf’s core businesses, Fruhstorfer continued, which will be sustainably strengthened by the acquisition.
 
“We are excited to have Eppendorf as a partner in acquiring our Centrifuge & Processing (C&P) business, which has held a first-place business track record in Japan for over 65 years,” said Atsushi Morisawa, CEO of Koki Holdings. “With Eppendorf’s investment through this acquisition, I am sure the Koki-originated C&P business will earn an extraordinary positioning in the global market. With that, Koki Holdings will strategically focus on the power tool industry to become the top brand globally.”

Related Topics

Published In

Volume 16 - Issue 4 | April 2020

April 2020

April 2020 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Laboratorian with a white coat and blue gloves pipettes green liquid into a beaker with multicolored liquids in beakers and tubes in the blue-tinged, sterile laboratory background.

Discovering cutting-edge nitrosamine analysis in pharmaceuticals

New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
A starry night sky reflected over calm water, symbolizing the discovery of hidden patterns in complex systems.

Technology Guide: Spatial biology techniques

Discover essential strategies and expert insights to navigate the expanding world of spatial biology.
Red tumor cells are shown against a teal backdrop showing attachment to tissue.

Decoding the tumor microenvironment with immune profiling

Integrating multiplexed immunohistochemistry with spatial analysis offers a practical way to uncover tumor-immune dynamics.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue